(Q43718405)

26 November 2017

title

The effect of antiretroviral therapy on HTLV infection (English)

1 reference

26 November 2017

Machuca A

1

1 reference

26 November 2017

Rodés B

series ordinal

2

1 reference

26 November 2017

Soriano V

series ordinal

3

1 reference

26 November 2017

publication date

1 October 2001

1 reference

26 November 2017

1 reference

26 November 2017

volume

78

1 reference

26 November 2017

issue

1-2

1 reference

26 November 2017

page(s)

93-100

1 reference

Positive effects of combined antiretroviral therapy on CD4+ T cell homeostasis and function in advanced HIV disease

26 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0168-1702%2801%2900287-8

7 January 2021

HTLV-I and HTLV-II virus expression increase with HIV-1 coinfection

1 reference

https://api.crossref.org/works/10.1016%2FS0168-1702%2801%2900287-8

7 January 2021

Peripheral nerve lesions in HTLV-I associated myelopathy (HAM/TSP).

1 reference

https://api.crossref.org/works/10.1016%2FS0168-1702%2801%2900287-8

7 January 2021

Clinical and neuropathological study of six patients with spastic paraparesis associated with HTLV-I: an axomyelinic degeneration of the central nervous system.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-1702%2801%2900287-8

7 January 2021

Quantification of HTLV-II proviral copies by competitive polymerase chain reaction in peripheral blood mononuclear cells of Italian injecting drug users, central Africans, and Amerindians

1 reference

https://api.crossref.org/works/10.1016%2FS0168-1702%2801%2900287-8

7 January 2021

Spastic ataxia associated with human T-cell lymphotropic virus type II infection

1 reference

https://api.crossref.org/works/10.1016%2FS0168-1702%2801%2900287-8

7 January 2021

Chronic neurodegenerative disease associated with HTLV-II infection.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-1702%2801%2900287-8

7 January 2021

Pathology of chronic myelopathy associated with HTLV-I infection (HAM/TSP).

1 reference

https://api.crossref.org/works/10.1016%2FS0168-1702%2801%2900287-8

7 January 2021

Interferon-alpha is effective in HTLV-I-associated myelopathy: a multicenter, randomized, double-blind, controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS0168-1702%2801%2900287-8

7 January 2021

Isolation of HTLV-II from a patient with chronic, progressive neurological disease clinically indistinguishable from HTLV-I-associated myelopathy/tropical spastic paraparesis

1 reference

https://api.crossref.org/works/10.1016%2FS0168-1702%2801%2900287-8

7 January 2021

HLA alleles determine human T-lymphotropic virus-I (HTLV-I) proviral load and the risk of HTLV-I-associated myelopathy

1 reference

https://api.crossref.org/works/10.1016%2FS0168-1702%2801%2900287-8

7 January 2021

An enhanced-sensitivity branched-DNA assay for quantification of human immunodeficiency virus type 1 RNA in plasma.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-1702%2801%2900287-8

7 January 2021

Increased HTLV-I proviral DNA in HTLV-I-associated myelopathy: a quantitative polymerase chain reaction study

1 reference

https://api.crossref.org/works/10.1016%2FS0168-1702%2801%2900287-8

7 January 2021

Leukoencephalopathy in HTLV-I-associated myelopathy/tropical spastic paraparesis: MRI analysis and a two year follow-up study after corticosteroid therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0168-1702%2801%2900287-8

7 January 2021

Plasmapheresis in treatment of human T-lymphotropic virus type-I associated myelopathy

1 reference

https://api.crossref.org/works/10.1016%2FS0168-1702%2801%2900287-8

7 January 2021

HTLV-II associated myelopathy in 43-year-old woman. REDS Investigators.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-1702%2801%2900287-8

7 January 2021

High-dose zidovudine induction in HTLV-I-associated myelopathy: safety and possible efficacy

1 reference

https://api.crossref.org/works/10.1016%2FS0168-1702%2801%2900287-8

7 January 2021

Line probe assay for rapid detection of drug-selected mutations in the human immunodeficiency virus type 1 reverse transcriptase gene

1 reference

https://api.crossref.org/works/10.1016%2FS0168-1702%2801%2900287-8

7 January 2021

A search for human T-cell leukemia virus type I in the lesions of patients with tropical spastic paraparesis and polymyositis

1 reference

https://api.crossref.org/works/10.1016%2FS0168-1702%2801%2900287-8

7 January 2021

Prospective study of HTLV-I infection in an initially asymptomatic cohort.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-1702%2801%2900287-8

7 January 2021

Effect of lamivudine on human T-cell leukemia virus type 1 (HTLV-1) DNA copy number, T-cell phenotype, and anti-tax cytotoxic T-cell frequency in patients with HTLV-1-associated myelopathy

1 reference

https://api.crossref.org/works/10.1016%2FS0168-1702%2801%2900287-8

7 January 2021

Evaluation of a new HTLV-I/II polymerase chain reaction

1 reference

https://api.crossref.org/works/10.1016%2FS0168-1702%2801%2900287-8

7 January 2021

Clonal expansion of infected cells: a way of life for HTLV-I.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-1702%2801%2900287-8

7 January 2021

Investigation of proviral load in individuals infected with human T-lymphotropic virus type II.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-1702%2801%2900287-8

7 January 2021

Long-term, high dose interferon-alpha treatment in HTLV-I-associated myelopathy/tropical spastic paraparesis: a combined clinical, virological and immunological study

1 reference

https://api.crossref.org/works/10.1016%2FS0168-1702%2801%2900287-8

7 January 2021

Human T-lymphotropic virus type 2 (HTLV-2) provirus in circulating cells of the monocyte/macrophage lineage in patients dually infected with human immunodeficiency virus type 1 and HTLV-2 and having predominantly sensory polyneuropathy

1 reference

https://api.crossref.org/works/10.1016%2FS0168-1702%2801%2900287-8

7 January 2021

10.1016/S0168-1702(01)00287-8

Identifiers

DOI

1 reference

26 November 2017

1 reference